If you were to look under the hood of any big-name IPO these days – such as LinkedIn, Pandora, and someday, Facebook – you’d see a highly sophisticated coordination of capital sources that fueled each to that highly coveted spot: Seed or “Angel” money that got the idea off the ground was followed by early-stage … Continue reading “How a VC-Style Investment System Can Support a More Just and Humane World”
Author: Thane Kreiner
Thane Kreiner, Ph.D., is Executive Director of the Center for Science, Technology, and Society at Santa Clara University. The Center promotes the use of science and technology to benefit underserved populations worldwide. Its signature Global Social Benefit Incubator program has supported more than 140 socially-minded entrepreneurs build sustainable and scalable ventures that deliver essential goods and services to base of pyramid markets. Thane was formerly Founder, President, and CEO of PhyloTech, Inc., (now Second Genome), which conducts comprehensive microbial community analysis for environmental and human health applications. He was Founder, President and CEO of Presage Biosciences, Inc., a Seattle-based company dedicated to bringing better cancer drugs to market. Thane was the start-up President & CEO for iZumi Bio, Inc. (now iPierian), a regenerative medicine venture based on the break-through iPSc (induced pluripotent stem cell) technology. Prior to his efforts as a “parallel entrepreneur”, Thane spent 14 years in various senior leadership roles at Affymetrix, Inc., which pioneered the DNA chip industry. Thane earned his MBA from the Stanford Graduate School of Business; his PhD in Neurosciences from Stanford University School of Medicine; and his BS in Chemistry from the University of Texas, Austin.